Advertisement

Efficacy of the optimal ablation index–targeted strategy for pulmonary vein isolation in patients with atrial fibrillation: the OPTIMUM study results

  • So-Ryoung Lee
  • Eue-Keun ChoiEmail author
  • Eui-Jae Lee
  • Won-Seok Choe
  • Myung-Jin Cha
  • Seil Oh
MULTIMEDIA REPORT

Abstract

Purpose

The ablation index (AI) is a recently developed marker for ablation lesion quality that incorporates contact force (CF), time, and power in a weighted formula. There is a paucity of information on whether AI-guided pulmonary vein isolation (PVI) could improve the outcome in patients with atrial fibrillation (AF). We evaluated the optimal AI threshold for avoiding acute pulmonary vein reconnection (PVR), and to compare the efficacy of optimal AI-targeted PVI with that of conventional CF-guided PVI.

Methods

Seventy patients with AF (paroxysmal, 67%) were enrolled. In a phase 1 study, the patients underwent conventional CF-guided PVI (CON group), and the optimal AI threshold for avoiding acute PVR was identified. In phase 2, the patients underwent AI-guided PVI (OAI group). We compared the acute PVR rate between the CON group and the OAI group to demonstrate the efficacy of AI-guided PVI.

Results

In phase 1 (n = 38), acute PVR was observed in 57 of 532 (10.7%) segments. AI values of ≥ 450 at the anterior/roof segments and of ≥ 350 at the posterior/inferior/carina segments were identified as the optimal AI thresholds for avoiding acute PVR. In the phase 2 study targeting those AI values, the OAI group (n = 32) showed a significantly lower acute PVR rate than the CON group (4.2% vs. 10.7%, p < 0.001). The OAI group showed a higher minimum AI and smaller variations in AI values than the CON group.

Conclusions

Optimal AI-targeted PVI is feasible and could improve the acute outcome in patients with AF.

Trial registration

URL: https://www.clinicaltrials.gov. Unique identifier: NCT03389074.

Keywords

Atrial fibrillation Pulmonary vein isolation Ablation index 

Notes

Acknowledgments

We thank Cho-Rong Jeong, Ji Seon Park, Jiseon Lee, and Junyeop Yeo for their assistance.

Funding

This research was conducted with support from the investigator-initiated study program of Biosense Webster, Inc. (IIS 457).

Compliance with ethical standards

Conflict of interest

SRL, EJL, WSC, MJC, SO declare that they have no conflict of interest. EKC received a research grant from Daiichi-Sankyo, BMS/Pfizer, and Biosense Webster.

Supplementary material

10840_2019_565_MOESM1_ESM.docx (1.3 mb)
ESM 1 (DOCX 1345 kb)

References

  1. 1.
    Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–962.CrossRefGoogle Scholar
  2. 2.
    Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessions from a 5-year follow-up. Circulation. 2010;122:2368–77.CrossRefGoogle Scholar
  3. 3.
    Nery PB, Belliveau D, Nair GM, Bernick J, Redpath CJ, Szczotka A, et al. Relationship between pulmonary vein reconnection and atrial fibrillation recurrence: a systematic review and meta-analysis. JACC Clin Electrophysiol. 2016;2:474–83.CrossRefGoogle Scholar
  4. 4.
    Barnett AS, Bahnson TD, Piccini JP. Recent advances in lesion formation for catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9(5):e003299.CrossRefGoogle Scholar
  5. 5.
    Natale A, Reddy VY, Monir G, Wilber DJ, Lindsay BD, McElderry HT, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol. 2014;64:647–56.CrossRefGoogle Scholar
  6. 6.
    Reddy VY, Dukkipati SR, Neuzil P, Natale A, Albengue JP, Kautzner J, et al. Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath contact force ablation catheter study for atrial fibrillation (TOCCASTAR) study. Circulation. 2015;132:907–15.CrossRefGoogle Scholar
  7. 7.
    Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, et al. EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace. 2015;17:1229–35.CrossRefGoogle Scholar
  8. 8.
    Ullah W, McLean A, Tayebjee MH, Gupta D, Ginks MR, Haywood GA, et al. Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data. Heart Rhythm. 2016;13:1761–7.CrossRefGoogle Scholar
  9. 9.
    Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ, et al. Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace. 2017;19:775–83.Google Scholar
  10. 10.
    Wittkampf FH, Hauer RN, Robles de Medina EO. Control of radiofrequency lesion size by power regulation. Circulation. 1989;80:962–8.CrossRefGoogle Scholar
  11. 11.
    David EH. Determinants of lesion size during radiofrequency catheter ablation: the role of electrode-tissue contact pressure and duration of energy delivery. J Cardiovasc Electrophysiol. 1991;6:509–15.Google Scholar
  12. 12.
    Ikeda A, Nakagawa H, Lambert H, Shah DC, Fonck E, Yulzari A, et al. Relationship between catheter contact force and radiofrequency lesion size and incidence of steam pop in the beating canine heart: electrogram amplitude, impedance, and electrode temperature are poor predictors of electrode-tissue contact force and lesion size. Circ Arrhythm Electrophysiol. 2014;7:1174–80.CrossRefGoogle Scholar
  13. 13.
    Squara F, Latcu DG, Massaad Y, Mahjoub M, Bun SS, Saoudi N. Contact force and force-time integral in atrial radiofrequency ablation predict transmurality of lesions. Europace. 2014;16:660–7.CrossRefGoogle Scholar
  14. 14.
    Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol. 2013;6:327–33.CrossRefGoogle Scholar
  15. 15.
    Nakagawa H, Ikeda A, Govari A, Papaioannou T, Constantine G, Bar-Tal M. Prospective study using a new formula incorporating contact force, radiofrequency power and application time (force-power-time index) for quantifying lesion formation to guide long continuous atrial lesions in the beating canine heart. Circulation. 2013;128:A12104.Google Scholar
  16. 16.
    Suenari K, Nakano Y, Hirai Y, Ogi H, Oda N, Makita Y, et al. Left atrial thickness under the catheter ablation lines in patients with paroxysmal atrial fibrillation: insights from 64-slice multidetector computed tomography. Heart Vessel. 2013;28:360–8.CrossRefGoogle Scholar
  17. 17.
    Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systemic review and meta-analysis. J Am Heart Assoc. 2018;2:e004549.Google Scholar
  18. 18.
    Shah DC, Lambert H, Nakagawa H, Langenkamp A, Aeby N, Leo G. Area under the real-time contact force curve (force-time integral) predicts radiofrequency lesion size in an in vitro contractile model. J Cardiovasc Electrophysiol. 2010;21:1038–43.CrossRefGoogle Scholar
  19. 19.
    Kumar S, Morton JB, Lee J, Halloran K, Spence SJ, Gorelik A, et al. Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2012;5:1124–9.CrossRefGoogle Scholar
  20. 20.
    Schluermann F, Krauss T, Biermann J, Hartmann M, Trolese L, Pache G, et al. In vivo contact force measurements and correlation with left atrial anatomy during catheter ablation of atrial fibrillation. Europace. 2015;17:1526–32.CrossRefGoogle Scholar
  21. 21.
    Reddy VY, Pollak S, Lindsay BD, McElderry HT, Natale A, Kantipudi C, et al. Relationship between catheter stability and 12-month success atrial pulmonary vein isolation: a subanalysis of the SMART-AF trial. JACC Clin Electrophysiol. 2016;2:691–9.CrossRefGoogle Scholar
  22. 22.
    Münkler P, Kröger S, Liosis S, Abdin A, Lyan E, Eitel C, et al. Ablation index for catheter ablation of atrial fibrillation – clinical applicability and comparison with force-time integral. Circ J. 2018;82:2722–7.  https://doi.org/10.1253/circj.CJ-18-0361.CrossRefGoogle Scholar
  23. 23.
    El Haddad M, Taghji P, Phlips T, Wolf M, Demolder A, Choudhury R, et al. Determinants of acute and late pulmonary vein reconnection in contact force-guided pulmonary vein isolation: identifying the weakest link in the ablation chain. Circ Arrhythm Electrophysiol. 2017;10(4):3004867.CrossRefGoogle Scholar
  24. 24.
    Taghji P, El Haddad M, Phlips T, Wolf M, Knecht S, Vandekerckhove Y, et al. Evaluation of a strategy aiming to enclose the pulmonary veins with contiguous and optimized radiofrequency lesions in paroxysmal atrial fibrillation: a pilot study. JACC Clin Electrophysiol. 2018;4:99–108.CrossRefGoogle Scholar
  25. 25.
    Hussein A, Das M, Riva S, Morgan M, Ronayne C, Sahni A, et al. Use of ablation index-guided ablation results in high rates of durable pulmonary vein isolation and freedom from arrhythmia in persistent atrial fibrillation patients. Circ Arrhythm Electrophysiol. 2018;11:e006576.CrossRefGoogle Scholar
  26. 26.
    Phlips T, Taghji P, El Haddad M, Wolf M, Knecht S, Vandekerckhove Y, et al. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol. Europace. 2018;20:f419–27.  https://doi.org/10.1093/europace/eux376.CrossRefGoogle Scholar
  27. 27.
    Tanaka N, Inoue K, Tanaka K, Toyoshima Y, Oka T, Okada M, et al. Automated ablation annotation algorithm reduces re-conduction of isolated pulmonary vein and improves outcome after catheter ablation for atrial fibrillation. Circ J. 2017;81:1596–602.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • So-Ryoung Lee
    • 1
  • Eue-Keun Choi
    • 1
    Email author
  • Eui-Jae Lee
    • 1
  • Won-Seok Choe
    • 1
  • Myung-Jin Cha
    • 1
  • Seil Oh
    • 1
  1. 1.Department of Internal MedicineSeoul National University HospitalSeoulRepublic of Korea

Personalised recommendations